Status:
COMPLETED
HDL-Atherosclerosis Treatment Study (HATS)
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Disease
Eligibility:
All Genders
35-68 years
Phase:
PHASE3
Brief Summary
To measure the effects of lipid-lowering drugs and/or antioxidant vitamins on progression or regression of coronary heart disease as measured by quantitative angiography in patients with low high dens...
Detailed Description
BACKGROUND: More than one-third of patients with coronary disease have "low" high density lipoprotein cholesterol (HDLc) levels (less than 35 mg/dl; United States 20th percentile) and "normal" low de...
Eligibility Criteria
Men and women with low HDL cholesterol, with at least one 50% stenotic coronary lesion or three 30% stenotic coronary lesions. Women range in age from 35 to less than 68 and men from 35 to less than 63.
Key Trial Info
Start Date :
September 1 1994
Trial Type :
INTERVENTIONAL
End Date :
February 1 2001
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000553
Start Date
September 1 1994
End Date
February 1 2001
Last Update
February 10 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.